|
|
| | Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, 3-acetate, (3α)- Basic information |
| Product Name: | Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, 3-acetate, (3α)- | | Synonyms: | Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, 3-acetate, (3α)-;(3R,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate;Acetic acid abiolone impurity 8;(3alpha)-3-Acetate-17-(3-pyridinyl)-androsta-5,16-dien-3-ol;Abiraterone Acetate Impurity I;(3R)-Abiraterone Acetate | | CAS: | 2484719-10-8 | | MF: | C26H33NO2 | | MW: | 391.56 | | EINECS: | | | Product Categories: | | | Mol File: | 2484719-10-8.mol |  |
| | Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, 3-acetate, (3α)- Chemical Properties |
| Boiling point | 506.7±50.0 °C(Predicted) | | density | 1.14±0.1 g/cm3(Predicted) | | pka | 5.31±0.12(Predicted) |
| | Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, 3-acetate, (3α)- Usage And Synthesis |
| Uses | Abiraterone Acetate 3-α-Diastereomer is an isomer of Abiraterone acetate (A108500) which is a novel steroidal inhibitor of human Cytochrome P450 (17α-Hydroxylase-C17,20-lyase): potential agent for the treatment of prostatic cancer. |
| | Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, 3-acetate, (3α)- Preparation Products And Raw materials |
|